Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The entry "Bacterial membrane disruption by antimicrobial peptides tdAMP-1/tdAMP-2 against Gram-negative bacteria including Salmonella Typhi/E coli" does not refer to a single canonical molecular target such as a receptor, enzyme, or transporter. Instead, it describes the general mechanism of action for a class of molecules—antimicrobial peptides (AMPs), specifically tomato-derived AMPs named tdAMP-1 and tdAMP-2. These peptides exert their antibacterial effects primarily by disrupting the integrity of the bacterial cell membrane, leading to leakage of cellular contents and rapid bacterial death[6]. This is considered a broad biophysical effect rather than interaction with a discrete molecular target. Some AMPs can also enter cells and interfere with intracellular processes like protein synthesis or nucleic acid function; however, for most Trp/Arg-rich AMPs—including those similar in structure to tdAMPs—the primary mode is membrane permeabilization[1][3]. There is no evidence that these particular AMPs act on specific receptors or enzymes within bacteria. Because this entry refers to an action/mechanism rather than an individual molecule/receptor/protein that could be targeted by drugs in the conventional sense, it should be marked as incorrect for structured drug-target databases. The correct approach would be to list each AMP individually if needed ("Tomato-derived antimicrobial peptide 1", "Tomato-derived antimicrobial peptide 2") but not "bacterial membrane disruption" itself as a target. These tdAMPs have demonstrated potent antimicrobial properties by effectively disrupting bacterial membranes. The efficacy of tdAMP‑2 is shown... [6] Tryptophan‑ and arginine‑rich AMPs interact strongly with negatively charged components in Gram‑negative outer membranes; their main function is direct permeabilization/disruption rather than binding specific proteins.[1][3] In summary: this entry describes an antibacterial mechanism mediated by certain peptides—not a canonical druggable biological target—and should not be treated as such in structured data systems.
Disruption of bacterial cell membranes leading to cell death[6]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Antimicrobial peptide-mediated bacterial membrane disruption.